|Articles|June 4, 2020

Antibiotic Scorecards Lead to More Appropriate Prescribing

Antimicrobial stewardship education was conducted with de-identified provider-specific prescribing scorecards.

Antibiotic resistance is not solely driven by inappropriate prescribing, but inappropriate antibiotic prescriptions are largely responsible for the accelerated rate of resistance development.

In an abstract planned for presentation at the now-cancelled 23rd Annual Making a Difference in Infectious Diseases (MAD-ID) Conference, investigators from Saint Francis Hospital and Medical Center share results of a study in which antimicrobial stewardship education was conducted with de-identified provider-specific prescribing scorecards.

Previous study at Saint Francis Hospital and Medical Center had identified areas in need of improvement in outpatient prescribing for respiratory infections, urinary tract infections, and skin & soft tissue infections. Pharmacists intervened by providing education via prescribing scorecards and antibiotic algorithms for the previously mentioned indications.

The investigators reviewed outpatient antibiotic prescription data and medical records for patients in adult primary care clinics from July 2017-June 2018. A post-intervention time period, April-September 2019, was assessed as well.

The study team looked at patient demographics, antibiotic prescriptions, patient allergies, and indications. Investigators evaluated appropriate medication choice and therapy duration using documented indications and clinical practice guidelines.

“The primary outcome was the rate of inappropriate antibiotic prescriptions for respiratory infections, SSTIs and UTIs before and after providing education with the de-identified provider-specific prescribing scorecard,” investigators wrote.

Through the program, the rate of inappropriate antibiotic prescriptions in the 3 combined areas for improvement was reduced from 74% to 56% following us of the de-identified prescriber scorecard. Most improvement was driven by reductions in inappropriate prescribing for skin & soft tissue infections (97% pre-intervention, 67% post-intervention) and UTIs (60% pre-intervention, 19% post-intervention).

Inappropriate prescribing rates in respiratory infections were not significant (66% pre-intervention, 61% post- intervention).

The study team highlighted that a mere 1-time educational intervention led to an 18.4% decrease in the rate of inappropriate antibiotic prescriptions for 3 common indications.

The abstract, “Impact of antimicrobial stewardship education using a de-identified, provider-specific prescribing scorecard on outpatient antibiotic prescribing practices,” was published by the organizers of MAD-ID 2020.


Related to this article

Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.